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Abstract We evaluated the role of protein kinase C (PKC) in
the regulation of apoptosis triggered by singlet oxygen.
Activation of PKC by short-term 12-O-tetradecanoyl phorbol
13-acetate (TPA) treatment inhibited apoptosis, whereas inhibi-
tion of PKC with several inhibitors potentiated this process. The
antiapoptotic effect of TPA was accompanied by phosphoryla-
tion of extracelluar signal-regulated kinase 1/2 (ERK1/2).
Pretreatment of cells with MEK inhibitor, PD98059, inhibited
TPA-induced phosphorylation of ERK1/2 and the cytoprotective
ability of TPA. These results suggest that activation of PKC in
HL-60 cells confers protection against apoptosis induced by
singlet oxygen and that ERK1/2 mediates antiapoptotic signaling
of PKC.
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1. Introduction
Apoptosis is believed to play an important role in destruc-
tion of malignant cells treated with photodynamic therapy
(PDT) [1]. The mechanism of this therapy involves the for-
mation of reactive oxygen species (ROS) following the uptake
of a photosensitive dye and subsequent activation of the dye
with visible light. The types of ROS generated in this process
depend on the photosensitizing drug, its intracellular location
and the light wavelength. We have previously shown that ex-
citation of rose bengal (RB), a photosensitizer localizing in the
plasma membrane, with UVA irradiation produced radicals
and singlet oxygen, whereas with visible light irradiation it
produced only singlet oxygen [2]. Further studies indicated
that both species may be associated with induction of apop-
tosis [3].
The signaling mechanisms that mediate apoptosis in re-
sponse to PDT are being studied and are still unclear. A early
observation indicated the PDT-induced apoptosis did not in-
volve new protein or RNA synthesis in L5178 mouse lympho-
ma cells [4], whereas an increase in production of ceramide
was associated with DNA fragmentation [5]. Recently, Luo et
al. [6] reported that PDT-induced apoptosis could be attenu-
ated by inhibition of serine/threonine phosphatase 1 and 2A
and potentiated by a serine/threonine kinase inhibitor, sug-
gesting that serine/threonine dephosphorylation is required
for the initiation of apoptosis. In other words, activation of
one or more serine/threonine kinases could protect cells
against apoptosis. Although several serine/threonine kinases
are linked to antiapoptotic signaling [7^9], little is known
about the serine/threonine kinases involved in regulation of
singlet oxygen-induced apoptosis.
Protein kinase C (PKC) is a well known serine/threonine
kinase, consisting of three groups, cPKC (K, L, L2 and Q),
nPKC (N, O, R and a) and aPKC (j and S/V), and is involved
in many cellular functions, such as proliferation and di¡er-
entiation. Recently, a number of studies have shown that
PKC also participates in the regulation of apoptosis induced
by many stimuli, such as antitumor drugs, tumor necrosis
factor K (TNFK) and ionizing irradiation [10^12]. However,
the regulatory e¡ect of PKC on apoptosis is still controver-
sial ; PKC activation and PKC inhibition can, depending upon
the cell types and inducers used, either prevent or induce
apoptosis [13]. In HL-60 cells, downregulation of PKC poten-
tiates ara-C-induced apoptosis and activation of PKC by ex-
posure to PMA (phorbol-12-myristate 13-acetate) opposes
apoptosis induced by topoisomerase I and II inhibitors
[14,15]. In contrast to these ¢ndings, a stimulatory role of
PKC is suggested by the reported ability of PMA to enhance
nitric oxide-induced fragmentation of genomic DNA [16].
In this study, we have investigated the potential role of
PKC in regulation of apoptosis induced by singlet oxygen
and found that short-term treatment of cells with 12-O-tetra-
decanoyl phorbol 13-acetate (TPA), a PKC activator, protects
cells against apoptosis, whereas pharmacological inhibition of
PKC with various inhibitors potentiates this process, suggest-
ing that PKC functions as a negative regulator in singlet oxy-
gen-induced apoptosis. Further studies demonstrated that
ERK1/2 mediates the antiapoptotic signaling of PKC.
2. Materials and methods
2.1. Chemicals
TPA, H7, staurosporine and diamidino phenyl indole (DAPI) were
purchased from Sigma, GF109203X was from Calbiochem-Novabio-
chem, PD98059 was from Alexis and rose bengal was from Aldrich.
Rabbit polyclonal ERK (ERK1-CT) antibody was purchased from
Upstate Biotechnology and phospho-speci¢c p44/42 MAP kinase anti-
body was from New England Biolabs. Rabbit monoclonal Bcl-2 anti-
body was obtained from Santa Cruz Biotechnology.
2.2. Cell culture and treatment
Early passage human promyelocytic leukemia HL-60 cells, obtained
from the ATCC, were grown in suspension in RPMI 1640 medium
supplemented with 20% fetal bovine serum (FBS) in the absence of
antibiotics. Cells were passaged twice a week and used between pas-
sages 20 and 40. For cell photosensitization, cell suspensions in RPMI
1640 without phenol red and FBS were incubated with 3 WM RB for
15 min at room temperature and then exposed to visible light (514
nm) provided by a continuous wave argon laser (Innova 100, Coher-
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ent). The irradiance at the level of cells was 30 mW/cm2. After irra-
diation, cells were transferred to RPMI 1640 medium with 20% FBS
and incubated at 2U105 cells/ml for the indicated times before har-
vesting. When required, concentrated TPA (100 Wg/ml) was added to
the medium to give a ¢nal concentration of 100 ng/ml.
2.3. Morphology observations
Cell morphology was evaluated by £uorescence microscopy follow-
ing DAPI staining. Apoptotic cells were identi¢ed by features charac-
teristic of apoptosis (e.g. nuclear fragmentation and condensation,
formation of membrane blebs and apoptotic bodies). Necrotic cells
were determined by staining with 0.4% trypan blue. Five hundred cells
were counted for each sample and the numbers of apoptotic or ne-
crotic cells were expressed as the percentage of the total cell popula-
tion.
2.4. Analysis of DNA fragmentation
Cells (2U106/ml) were pelleted by centrifugation at 200Ug for
5 min. Cell pellets were resuspended in lysis bu¡er (10 mM Tris,
pH 8.0, 1 mM EDTA, pH 8.0, 1% SDS) and incubated in proteinase
K (10 Wg/ml) at 56‡C overnight. The lysates were then incubated with
ribonuclease A (10 Wg/ml) for 2 h at 37‡C. DNA preparations were
precipitated with 2-propanol and subsequently washed with 75% etha-
nol. After air-drying, the DNA pellets were resuspended in 30 Wl of
TE bu¡er, separated by horizontal electrophoresis on 1.5% agarose
gels, stained with 0.5 Wg/ml ethidium bromide, and visualized under
ultraviolet light.
2.5. Western blot analysis
Cells were centrifuged for 5 min at 200Ug, washed once with phos-
phate-bu¡ered saline without calcium chloride and magnesium chlo-
ride and then suspended in the lysis bu¡er (0.25 M Tris-HCl, pH 6.8,
4% SDS, 10% glycerol, 1 mg/ml bromophenol blue, and 0.5% 2-mer-
captoethanol). Equal amounts of total cellular protein lysates were
separated on 10% polyacrylamide gels. For detection of the phos-
phorylated form of Bcl-2, 12% polyacrylamide gels were used and
electrophoretically transferred to nitrocellulose membranes. After
treatment of the membrane with 5% skim milk at 4‡C overnight,
the membranes were incubated sequentially with the indicated pri-
mary antibodies followed by an appropriate horseradish peroxidase-
conjugated secondary antibody. Bound antibodies were visualized
with chemiluminescence detection on autoradiographic ¢lm.
3. Results
We have investigated apoptosis initiated by singlet oxygen
in HL-60 cells. Singlet oxygen was generated by RB photo-
sensitization. As shown in Fig. 1, exposure of cells to visible
light (514 nm) at a dose of 300 mJ/cm2 in the presence of 3 WM
RB induced typical morphological features of apoptosis as
characterized by fragmented nuclei and the formation of
apoptotic bodies following 2.5 h incubation. In contrast, nei-
ther visible light nor RB alone increased the number of apop-
totic cells compared to control samples (data not shown).
Consistent with these results, agarose gel electrophoresis re-
vealed that photosensitization with RB caused DNA cleavage
with the characteristic pattern of internucleosomal fragmenta-
tion produced by apoptosis whereas DNA from cells irradi-
ated by visible light in the absence of RB or exposure of cells
to RB without irradiation was unfragmented (data not
shown). These results suggest that generation of singlet oxy-
gen by photosensitization can induce apoptosis in HL-60 cells.
Analysis of the time course showed that DNA fragmenta-
tion was barely visible at 1 h after photosensitization and
increased progressively with incubation time (Fig. 2A); lad-
dering was most apparent at 4 h and decreased with further
incubation. Staining of photosensitized cells with trypan blue,
indicative of necrosis, increased with incubation time (1^5 h)
(Fig. 2B). DNA fragmentation induced by singlet oxygen also
increased with light dose, with a maximum e¡ect produced by
300^420 mJ/cm2. In this experiment, photosensitization with
RB was followed by 2.5 h incubation; DNA ladders became
apparent at 180 mJ/cm2 (Fig. 2C). Doses of light over 540 mJ/
cm2 inhibited formation of DNA laddering although trypan
blue staining of cells increased in a dose-dependent fashion
(Fig. 2D). These results indicate that lower doses of light or
shorter incubation time following photosensitization produce
apoptosis, but higher light doses or longer incubation time are
associated with necrosis. For our studies of the regulatory
mechanism of singlet oxygen-induced apoptosis, 300 mJ/cm2
of 514 light and 2.5 h of incubation were used for the follow-
ing experiments.
It has been reported that the alteration of PKC activity is
associated with modulation of apoptosis induced by a variety
of stimuli [13,17]. We were interested in determining whether
PKC is involved in the regulation of apoptosis induced by
singlet oxygen. To investigate the e¡ect of PKC on singlet
oxygen-induced apoptosis, we ¢rst examined the e¡ect of
TPA, a potent PKC activator. It is well known that TPA
can activate c and nPKC after short-term treatment [18]. As
shown in Fig. 3, incubation of cells with TPA dramatically
inhibited the expression of apoptotic morphology in response
to visible light plus RB. In contrast to the e¡ect of TPA, 4-K-
TPA, an analogue of TPA without the ability to activate
PKC, had no e¡ect. These results suggest that the activation
of PKC protects cells against apoptosis induced by singlet
oxygen.
The role of PKC in singlet oxygen-induced apoptosis was
further evaluated by using three PKC inhibitors. H7 and
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Fig. 1. Singlet oxygen generated by photosensitization with rose
bengal and 514 nm light induces apoptosis in HL-60 cells. HL-60
cells (2U106/ml) were treated with vehicle or RB (3 WM) for 15 min
and then either left untreated or irradiated with 514 light at a dose
of 300 mJ/cm2. After incubation in the complete medium for 2.5 h,
cells were harvested and stained with DAPI. a: Control; b: photo-
sensitization with RB plus light (PS). Results are representative of
three independent experiments.
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staurosporine are non-speci¢c PKC inhibitors, which have
been shown to be able to induce apoptosis in HL-60 cells
[19]. In contrast, GF109203X is a highly selective PKC inhib-
itor [20]. To investigate the e¡ect of these PKC inhibitors on
singlet oxygen-induced apoptosis, cells were pretreated with
each agent for 1 h, and then exposed to light plus RB. As
shown in Fig. 4, all the PKC inhibitors potentiated the apop-
totic response to singlet oxygen, with the greatest e¡ect in
staurosporine-treated cells. Incubation of cells with each in-
hibitor alone for 2.5 h only had a minor e¡ect. Thus, these
data, together with the e¡ect of short-term TPA treatment,
suggest that PKC mediates antiapoptotic signaling in singlet
oxygen-induced apoptosis.
Since the activation of ERK has been reported to play an
antiapoptotic role in several systems [21^23], we asked
whether the antiapoptotic action conferred by TPA was
through the activation of ERK pathways. To test this possi-
bility we investigated the e¡ect of a highly speci¢c MEK in-
hibitor, PD98059, on TPA-mediated protection in singlet oxy-
gen-induced apoptosis. As shown in Fig. 5A, incubation of
cells in RPMI 1640 medium containing 20% FBS caused a
baseline ERK1/2 phosphorylation (lane 1 and 5); photosensi-
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Fig. 2. Time course for singlet oxygen-induced cell death as estimated by DNA fragmentation and trypan blue staining. Cells (2U106/ml) were
treated with RB (3 WM) for 15 min and irradiated with 300 mJ/cm2 of 514 nm light. After incubation for the indicated times, cells were har-
vested for DNA analysis on a 1.5% agarose gel (A) or stained with 0.4% trypan blue and then counted (B). Cells (2U106) were treated with
RB as above and then irradiated with a variety of doses of 514 nm light as indicated. After incubation for 2.5 h, cells were harvested for
DNA fragmentation analysis (C) or stained with trypan blue and then counted (D). Results are representative of three independent experi-
ments.
Fig. 3. Activation of PKC by TPA protects cells from singlet oxy-
gen-induced apoptosis. After photosensitization with 3 WM RB plus
300 mJ/cm2 514 nm light, cells were incubated in complete medium
containing TPA (100 ng/ml) or 4-K-TPA (100 ng/ml) for 2.5 h and
then harvested. Apoptotic cells were assessed as described in Section
2. Values are means þ S.D. of the data from three independent ex-
periments. PS indicates photosensitization with RB plus 514 nm
light.
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tization with RB had no further e¡ect (lane 2). However,
pretreatment of cells with TPA induced a phosphorylation
of ERK1/2 above baseline (lane 3). This phosphorylation
could be abolished by MEK inhibitor, PD98059 (lanes 4
and 7).
Fig. 5B shows that treatment of cells with PD98059 also
abolished the antiapoptotic ability of TPA. Incubation of cells
with 100 ng/ml of TPA led to inhibition of singlet oxygen-
induced apoptosis by 52%. In the presence of PD98059, TPA-
treated cells resumed almost their full ability to undergo apop-
tosis in response to singlet oxygen. PD98059 itself slightly
enhanced apoptosis. These results indicate that activation of
ERK1/2 is required for mediating the antiapoptotic e¡ect of
PKC.
4. Discussion
The induction of apoptosis by PDT depends on the forma-
tion of ROS, including singlet oxygen and radicals. We have
previously shown that singlet oxygen generated in plasma
membrane is more e¡ective than radicals produced from RB
in the same site for initiation of apoptosis in HL-60 cells [3].
In this study, we have shown that activation of PKC by TPA
suppresses singlet oxygen-induced apoptosis and that the cy-
toprotective ability of TPA is associated with activation of
ERK1/2.
Although several reports have demonstrated that activation
of PKC protects cells against apoptosis [10^12], the mecha-
nisms for this antiapoptotic activity are not well de¢ned. It
has been demonstrated that expression of Bcl-2, an antiapop-
totic protein, is increased following short-term phorbol ester
treatment in the immature Ramos B-cell line, and up-regula-
tion of expression of Bcl-2 increases cell resistance to apopto-
sis [24,25]. In HL-60 cells, induction of apoptosis by ara-C has
been shown to be associated with down-regulation of Bcl-2
[26]. However, apoptosis induced by photosensitization is a
rapid process, which does not require new protein synthesis
[4]. Consistent with this ¢nding, the Bcl-2 level was unchanged
throughout the 5 h time course examined following photo-
sensitization (data not shown). In addition, incubation with
TPA also did not alter Bcl-2 expression in photosensitized
cells. These results indicate that suppression of apoptosis by
TPA was not through regulating expression of Bcl-2. Re-
cently, May et al. have reported that PKC activation results
in the rapid phosphorylation of Bcl-2, which is required for its
antiapoptotic function in murine myeloid cell line, FDC-P1/
ER and NFS/N1.H7 [27]. However, Bcl-2 phosphorylation
was not seen following TPA treatment in HL-60 cells (data
not shown), suggesting that the antiapoptotic e¡ect exerted by
PKC activation does not involve Bcl-2 phosphorylation in this
cell line.
In addition to Bcl-2, PKC also interacts with other signal-
ing molecules which can mediate cell survival. This is illus-
trated by observations such as those of Kyriakis et al. [28]
where PKC activation results in the rapid phosphorylation
and activation of c-raf kinase, which in turn sequentially ac-
tivates MEK and ERK kinases. In addition, reports from
several laboratories show that ERK mediates an antiapoptotic
signal in various stimuli-induced apoptosis [21^23]. In this
study, we have demonstrated that activation of PKC by
TPA induced ERK1/2 phosphorylation and subsequently in-
hibited apoptosis, and that these e¡ects were abolished by
blockade of ERK1/2 activation (Fig. 5), suggesting that
ERK is necessary for mediating the antiapoptotic e¡ect of
PKC in HL-60 cells.
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Fig. 4. PKC inhibitors enhance singlet oxygen-induced apoptosis.
Cells were treated with vehicle (Con), 5 WM GF109203X (GF), 10
WM H7 or 100 nM staurosporine (Staur) for 1 h followed by photo-
sensitization (PS) with 3 WM RB plus 300 mJ/cm2 light. After incu-
bation for 2.5 h in the presence of the agents, cells were harvested
and stained with DAPI. Apoptotic cells were scored as described in
Section 2. Values are means þ S.D. of the data from three independ-
ent experiments.
Fig. 5. PD98059 inhibits TPA-mediated ERK1/2 phosphorylation
and abrogates the antiapoptotic e¡ect of TPA. Cells were treated
with vehicle or 20 WM PD98059 for 30 min followed by photosensi-
tization (PS) with 3 WM RB plus 300 mJ/cm2 light. After incubation
for 2.5 h in the presence or absence of 100 ng/ml TPA, cell lysates
were subjected to SDS-PAGE analysis and blotted with antibodies
to phospho-ERK1/2 or ERK1/2 (representative of three experi-
ments) (A) or apoptotic cells were evaluated as described in Section
2 after staining with DAPI. Values are means þ S.D. of the data
from three independent experiments (B).
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How ERK activation inhibits apoptosis remains to be de-
termined. Xie et al. [23] have reported that ERK and JNK/
p38 kinases play opposing e¡ects on apoptosis induced by
NGF withdrawal in rat pheochromocytoma PC-12 cell, acti-
vation of ERK and suppression of JNK/SAPK promoting cell
survival, while activation of JNK and p38 and inhibition of
ERK inducing apoptosis. This model was further extended by
Spiegel et al. in HL-60 cells indicating that a balance between
levels of sphingolipid metabolites, sphingosine-1-phosphate
(SPP) and ceramide, and their e¡ects on the ERK and JNK
pathways may be critical in determining whether a cell surviv-
al or undergoes apoptosis [29]. It has been reported that pho-
tosensitization of cells stimulated an increase in synthesis of
ceramide and activated JNK/p38 [5,30], while activation of
PKC by TPA could inhibit neutral sphingomyelinase activa-
tion and ceramide production and stimulate sphingosine kin-
ase activity and increased SPP [29,31]. Thus, it is reasonable
to speculate that the TPA-mediated antiapoptotic e¡ect might
be mediated by an increase of SPP and subsequent activation
of ERK and inhibition of the stress proteins, JNK or p38.
Agarwal et al. [32] have reported that apoptosis in mouse
lymphoma cells photosensitized with aluminum phthalocya-
nine was associated with phospholipase activation, and the
inhibitors for phospholipase C (PLC) could block the forma-
tion of fragmentation of nuclear DNA, implying that activa-
tion of PLC is associated with initiation of apoptosis. Since
activated PLC hydrolyzes the lipids, resulting in the produc-
tion of DAG, a direct endogenous activator of PKC, it seems
that in this system PKC might function as a potential down-
stream target that links intracellular lipid signal to induction
of apoptosis by PDT. If this is case, it would be contrary to
our results. A possible explanation for this di¡erence is that
the activation of PLC by photosensitization may mainly sig-
nal to other downstream molecules which trigger apoptosis. It
has been reported that PLC is not only associated with acti-
vation of PKC, but also with production of ceramide, a me-
diator for apoptosis induced by various stimuli [33]. In addi-
tion, It is also possible that production of di¡erent types of
ROS by photosensitization of di¡erent photosensitizers, may
trigger distinct signaling pathways responsible for apoptosis.
In summary, the ¢ndings of this study indicate that activa-
tion of PKC is able to confer resistance to apoptosis induced
by singlet oxygen generated in the plasma membrane and that
ERK is required for transducing the antiapoptotic signaling.
How activation of ERK a¡ects antiapoptotic signaling needs
further investigation.
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